Company Overview
Snapshot
Founded in October 2022 by Nir Sinai and Adiel Barak, Supra Medical operates with 1–10 employees. The company has secured funding across two Seed rounds, with Alon MedTech Ventures participating in both. In August 2025, Supra Medical received its latest Seed funding.
Business overview
Supra Medical is a medical device startup focused on developing an in-office injector for suprachoroidal drug delivery in ophthalmology. Its core technology enables ophthalmologists to administer drugs effectively and safely for various eye conditions, improving treatment outcomes and paving the way for gene therapies. The company operates within the Health Tech & Life Sciences sector, specifically in Pharma & Medical Biotechnology and Drug Delivery, serving the North American and European markets.
Log in to access full profile ›Company Intelligence Q&A
- When was Supra Medical founded?
- Supra Medical was founded in October 2022 by Nir Sinai and Adiel Barak.
- What is Supra Medical's core product?
- Supra Medical's core product is an innovative in-office injector for the suprachoroidal space, designed for safe and effective ophthalmic drug administration.
- What is the primary market Supra Medical serves?
- Supra Medical primarily serves the Healthcare & Life Sciences market, focusing on ophthalmologists and patients requiring treatments for various eye conditions.
- When did Supra Medical last raise funding?
- Supra Medical secured its Seed funding round in August 2025 from Alon MedTech Ventures.
- Which investor has participated in Supra Medical's funding rounds?
- Alon MedTech Ventures has participated in Supra Medical's Seed funding rounds, leading the round in November 2022 and following on in August 2025.